BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 11997281)

  • 1. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
    Yang P; Kanki H; Drolet B; Yang T; Wei J; Viswanathan PC; Hohnloser SH; Shimizu W; Schwartz PJ; Stanton M; Murray KT; Norris K; George AL; Roden DM
    Circulation; 2002 Apr; 105(16):1943-8. PubMed ID: 11997281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic background predisposing the drug-induced long QT syndrome].
    Horie M
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):401-7. PubMed ID: 12835534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.
    Paulussen AD; Gilissen RA; Armstrong M; Doevendans PA; Verhasselt P; Smeets HJ; Schulze-Bahr E; Haverkamp W; Breithardt G; Cohen N; Aerssens J
    J Mol Med (Berl); 2004 Mar; 82(3):182-8. PubMed ID: 14760488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence.
    Berthet M; Denjoy I; Donger C; Demay L; Hammoude H; Klug D; Schulze-Bahr E; Richard P; Funke H; Schwartz K; Coumel P; Hainque B; Guicheney P
    Circulation; 1999 Mar; 99(11):1464-70. PubMed ID: 10086971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long QT syndromes: genetic basis and clinical implications.
    Chiang CE; Roden DM
    J Am Coll Cardiol; 2000 Jul; 36(1):1-12. PubMed ID: 10898405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome.
    Van Langen IM; Birnie E; Alders M; Jongbloed RJ; Le Marec H; Wilde AA
    J Med Genet; 2003 Feb; 40(2):141-5. PubMed ID: 12566525
    [No Abstract]   [Full Text] [Related]  

  • 10. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
    Priori SG; Cantù F; Schwartz PJ
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
    Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
    Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.
    Swan H; Viitasalo M; Piippo K; Laitinen P; Kontula K; Toivonen L
    J Am Coll Cardiol; 1999 Sep; 34(3):823-9. PubMed ID: 10483966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiological mechanism of long QT syndrome and the effects of macrolides].
    Kato T
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():118-22. PubMed ID: 11439888
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation detection in long QT syndrome: a comprehensive set of primers and PCR conditions.
    Syrris P; Murray A; Carter ND; McKenna WM; Jeffery S
    J Med Genet; 2001 Oct; 38(10):705-10. PubMed ID: 11594341
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
    Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia.
    Sanguinetti MC
    Ann N Y Acad Sci; 1999 Apr; 868():406-13. PubMed ID: 10414310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
    Anderson ME; Al-Khatib SM; Roden DM; Califf RM;
    Am Heart J; 2002 Nov; 144(5):769-81. PubMed ID: 12422144
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1.
    Splawski I; Shen J; Timothy KW; Vincent GM; Lehmann MH; Keating MT
    Genomics; 1998 Jul; 51(1):86-97. PubMed ID: 9693036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac arrhythmias: the genetic connection.
    Towbin JA
    J Cardiovasc Electrophysiol; 2000 May; 11(5):601-2. PubMed ID: 10826942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.